News & Updates

Show Multimedia Only
PDE5is do not induce ocular adverse events PDE5is do not induce ocular adverse events

PDE5is do not induce ocular adverse events

10 Jan 2024

Use of phosphodiesterase 5 inhibitor (PDE5i) for erectile dysfunction (ED) or benign prostatic hyperplasia (BPD) does not seem to heighten the risk of ocular events in men, reveals a study.

10 Jan 2024